CERTS presentation on drug risk workshops
The Centers for Education and Research on Therapeutics will present the research and education agenda resulting from its five therapeutic risk workshops March 6 at the National Press Club in Washington, D.C., at 9 a.m. Workshops to date have covered risk communication, risk assessment and benefit assessment; risk communication & the media will be held on Jan. 7-8 and risk management on Jan. 13-14. The workshops are co-sponsored by CERTs, PhRMA, AHRQ and FDA (1"The Pink Sheet" July 8, p. 21)...
You may also be interested in...
The public reaction to the withdrawal of Bayer's Baycol (cerivastatin) may have caused more harm than the toxicity associated with the drug, Duke Centers for Education & Research on Therapeutics Principal Investigator Robert Califf, MD, told a CERTs workshop in Chapel Hill, N.C., Jan. 8
The Institute of Medicine should study the current state of pharmaceutical risk assessment and recommend methodological and research improvements, participants in a Centers for Education & Research on Therapeutics risk assessment workshop suggested
The decision limits US FDA discretion in determining how to regulate products that seem to meet both drug and device standards.